The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Glipizide (CAS 29094-61-9), C21H27N5O4S, the formula weight is 445.54, and its form is white cyrstal powder.
The global Glipizide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Glipizide is a hypoglycemic drug for non-insulin-dependent (II) type diabetes, which is used in patients with mild to moderate non-insulin-dependent patients who fail to achieve good results with diet control alone.
This report aims to provide a comprehensive presentation of the global market for Glipizide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glipizide.
Report Scope
The Glipizide market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glipizide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glipizide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
United Laboratories
Disha Pharma
PIDI
Lukang Pharma
Jingfeng Zhiyao
Jumpcan
CCPC
Yashica Pharma
Apotex
TEVA
Segment by Type
Glipizide Tablets
Glipizide Sustained Release Tablets
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glipizide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glipizide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glipizide (CAS 29094-61-9), C21H27N5O4S, the formula weight is 445.54, and its form is white cyrstal powder.
The global Glipizide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Glipizide is a hypoglycemic drug for non-insulin-dependent (II) type diabetes, which is used in patients with mild to moderate non-insulin-dependent patients who fail to achieve good results with diet control alone.
This report aims to provide a comprehensive presentation of the global market for Glipizide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glipizide.
Report Scope
The Glipizide market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glipizide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glipizide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
United Laboratories
Disha Pharma
PIDI
Lukang Pharma
Jingfeng Zhiyao
Jumpcan
CCPC
Yashica Pharma
Apotex
TEVA
Segment by Type
Glipizide Tablets
Glipizide Sustained Release Tablets
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glipizide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glipizide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glipizide Market Overview
1.1 Product Overview and Scope of Glipizide
1.2 Glipizide Segment by Type
1.2.1 Global Glipizide Market Value Comparison by Type (2024-2030)
1.2.2 Glipizide Tablets
1.2.3 Glipizide Sustained Release Tablets
1.2.4 Others
1.3 Glipizide Segment by Application
1.3.1 Global Glipizide Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Glipizide Market Size Estimates and Forecasts
1.4.1 Global Glipizide Revenue 2019-2030
1.4.2 Global Glipizide Sales 2019-2030
1.4.3 Global Glipizide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glipizide Market Competition by Manufacturers
2.1 Global Glipizide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glipizide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glipizide Average Price by Manufacturers (2019-2024)
2.4 Global Glipizide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glipizide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glipizide, Product Type & Application
2.7 Glipizide Market Competitive Situation and Trends
2.7.1 Glipizide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glipizide Players Market Share by Revenue
2.7.3 Global Glipizide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glipizide Retrospective Market Scenario by Region
3.1 Global Glipizide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glipizide Global Glipizide Sales by Region: 2019-2030
3.2.1 Global Glipizide Sales by Region: 2019-2024
3.2.2 Global Glipizide Sales by Region: 2025-2030
3.3 Global Glipizide Global Glipizide Revenue by Region: 2019-2030
3.3.1 Global Glipizide Revenue by Region: 2019-2024
3.3.2 Global Glipizide Revenue by Region: 2025-2030
3.4 North America Glipizide Market Facts & Figures by Country
3.4.1 North America Glipizide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glipizide Sales by Country (2019-2030)
3.4.3 North America Glipizide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glipizide Market Facts & Figures by Country
3.5.1 Europe Glipizide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glipizide Sales by Country (2019-2030)
3.5.3 Europe Glipizide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glipizide Market Facts & Figures by Country
3.6.1 Asia Pacific Glipizide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glipizide Sales by Country (2019-2030)
3.6.3 Asia Pacific Glipizide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glipizide Market Facts & Figures by Country
3.7.1 Latin America Glipizide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glipizide Sales by Country (2019-2030)
3.7.3 Latin America Glipizide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glipizide Market Facts & Figures by Country
3.8.1 Middle East and Africa Glipizide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glipizide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glipizide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glipizide Sales by Type (2019-2030)
4.1.1 Global Glipizide Sales by Type (2019-2024)
4.1.2 Global Glipizide Sales by Type (2025-2030)
4.1.3 Global Glipizide Sales Market Share by Type (2019-2030)
4.2 Global Glipizide Revenue by Type (2019-2030)
4.2.1 Global Glipizide Revenue by Type (2019-2024)
4.2.2 Global Glipizide Revenue by Type (2025-2030)
4.2.3 Global Glipizide Revenue Market Share by Type (2019-2030)
4.3 Global Glipizide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glipizide Sales by Application (2019-2030)
5.1.1 Global Glipizide Sales by Application (2019-2024)
5.1.2 Global Glipizide Sales by Application (2025-2030)
5.1.3 Global Glipizide Sales Market Share by Application (2019-2030)
5.2 Global Glipizide Revenue by Application (2019-2030)
5.2.1 Global Glipizide Revenue by Application (2019-2024)
5.2.2 Global Glipizide Revenue by Application (2025-2030)
5.2.3 Global Glipizide Revenue Market Share by Application (2019-2030)
5.3 Global Glipizide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Glipizide Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 United Laboratories
6.2.1 United Laboratories Corporation Information
6.2.2 United Laboratories Description and Business Overview
6.2.3 United Laboratories Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 United Laboratories Glipizide Product Portfolio
6.2.5 United Laboratories Recent Developments/Updates
6.3 Disha Pharma
6.3.1 Disha Pharma Corporation Information
6.3.2 Disha Pharma Description and Business Overview
6.3.3 Disha Pharma Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Disha Pharma Glipizide Product Portfolio
6.3.5 Disha Pharma Recent Developments/Updates
6.4 PIDI
6.4.1 PIDI Corporation Information
6.4.2 PIDI Description and Business Overview
6.4.3 PIDI Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PIDI Glipizide Product Portfolio
6.4.5 PIDI Recent Developments/Updates
6.5 Lukang Pharma
6.5.1 Lukang Pharma Corporation Information
6.5.2 Lukang Pharma Description and Business Overview
6.5.3 Lukang Pharma Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lukang Pharma Glipizide Product Portfolio
6.5.5 Lukang Pharma Recent Developments/Updates
6.6 Jingfeng Zhiyao
6.6.1 Jingfeng Zhiyao Corporation Information
6.6.2 Jingfeng Zhiyao Description and Business Overview
6.6.3 Jingfeng Zhiyao Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jingfeng Zhiyao Glipizide Product Portfolio
6.6.5 Jingfeng Zhiyao Recent Developments/Updates
6.7 Jumpcan
6.6.1 Jumpcan Corporation Information
6.6.2 Jumpcan Description and Business Overview
6.6.3 Jumpcan Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jumpcan Glipizide Product Portfolio
6.7.5 Jumpcan Recent Developments/Updates
6.8 CCPC
6.8.1 CCPC Corporation Information
6.8.2 CCPC Description and Business Overview
6.8.3 CCPC Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CCPC Glipizide Product Portfolio
6.8.5 CCPC Recent Developments/Updates
6.9 Yashica Pharma
6.9.1 Yashica Pharma Corporation Information
6.9.2 Yashica Pharma Description and Business Overview
6.9.3 Yashica Pharma Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yashica Pharma Glipizide Product Portfolio
6.9.5 Yashica Pharma Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Corporation Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Apotex Glipizide Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 TEVA
6.11.1 TEVA Corporation Information
6.11.2 TEVA Glipizide Description and Business Overview
6.11.3 TEVA Glipizide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TEVA Glipizide Product Portfolio
6.11.5 TEVA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glipizide Industry Chain Analysis
7.2 Glipizide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glipizide Production Mode & Process
7.4 Glipizide Sales and Marketing
7.4.1 Glipizide Sales Channels
7.4.2 Glipizide Distributors
7.5 Glipizide Customers
8 Glipizide Market Dynamics
8.1 Glipizide Industry Trends
8.2 Glipizide Market Drivers
8.3 Glipizide Market Challenges
8.4 Glipizide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
